Matairesinol.
Research-backed compound with potential health benefits. The theory: it's a phytoestrogen that might help balance hormones and act as an antioxidant. In your body, it converts to enterolactone, which is where the supposed benefits come from.
Reviewed March 2026
- Category
- Compound
What Matairesinol is, and what it does.
- Does it work
- Suits people who want a defined lignan intake alongside flax foods, or who track enterolactone. Human trials on the isolate are few, so this is a marker story more than a felt one.
- How much to take
- There's no established dose. Studies are all over the place, using everything from 50mg to 500mg. It's hard to recommend a specific amount.
- Time to feel it
- Plasma enterolactone rises within days of steady intake. Anything downstream of that is a months long story read from bloodwork rather than from how you feel.
- The first dose
- Nothing registers on day one. The lignan is heading for your colon, where bacteria start converting it to enterolactone, and plasma enterolactone climbs over the following days.
- With regular use
- Theoretically, you might see subtle shifts in hormone markers or cholesterol over many months. But honestly, you probably won't notice a thing.
- How well tolerated
- Seems well tolerated for most. The main flag is its phytoestrogen activity. If you have a history of hormone-related cancers or are on hormone therapy, this is one to skip without a doctor's okay.
- How it feels
- Like nothing. It's a background player with very subtle, unproven effects. You will not feel this work.
- The overlooked benefit
- Your gut bacteria decide how much you get. The same dose produces very different enterolactone levels between people, and a recent antibiotic course lowers it.
10 to 25mg a day is where Matairesinol works.
Source: Milder et al., Br J Nutr 2005; lignan metabolism research
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Matairesinol is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- plasma and urinary enterolactone levelsRandomised trial
- cholesterol already in the normal rangeRandomised trial
- weak oestrogen receptor binding as a phytoestrogenNarrative review
- antioxidant activity in laboratory testingIn vitro study
- cardiometabolic markers in populations with higher lignan intakeCohort study
Questions people ask about Matairesinol.
- Is this the same as flaxseed oil?
- No. Matairesinol is one specific compound *in* flaxseed. Flax oil has many other things like omega-3s. Eating ground flaxseed is a better source for this.
- Will it mess with my testosterone?
- Unlikely at typical doses. While it's a phytoestrogen, the effect is very weak and shouldn't impact testosterone levels in most men.
- Can I just get this from food?
- Yes, and you probably should. Flaxseed and sesame seeds are the best sources. You're better off eating the food than buying an isolated supplement.
- Is it an antioxidant?
- Yes, it has antioxidant properties in a test tube. Whether that translates to a meaningful effect in the human body is the big, unanswered question.
- Do I need special gut bacteria for it to work?
- Yes. Your gut microbes convert it into the active form, enterolactone. If your gut health is poor, you may not get any benefit.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Matairesinol has little activity until colonic bacteria demethylate and dehydroxylate it into enterolactone. The size and make-up of that bacterial population sets how much conversion happens.
Lactobacilli are among the genera carrying the enzymes that step plant lignans toward enterolactone. Adding them supports the conversion route matairesinol depends on.
Fermentable fibre feeds the colonic bacteria that carry out lignan conversion and lowers colonic pH. That shifts more matairesinol toward its active enterolignan form.
Enterolactone from matairesinol and isoflavones both bind estrogen receptors weakly, with a preference for the beta subtype. Their occupancy at those receptors is additive and both are handled by the same gut conversion and conjugation machinery.
Matairesinol is not the active species that reaches circulation. Colonic bacteria including bifidobacteria deglycosylate, demethylate and dehydroxylate plant lignans to enterolactone, and it is enterolactone that is absorbed and measured in blood and urine. That conversion step is why the composition of a person's microbiota, more than the dose of lignan, determines how much enterolignan they produce.
The multi-step conversion of a plant lignan to enterolactone requires several bacterial enzyme activities that no single species holds alone, and lactobacilli contribute to that consortium. Supplying the substrate without the converting organisms leaves much of it unconverted. The relationship is established microbial biochemistry rather than a measured combination outcome.
Bifidobacteria carry glycoside hydrolases that perform the first deglycosylation step on plant lignan glycosides before other genera complete the conversion to enterolactone. A formula combining the lignan with these organisms is supplying substrate and converter together. Whether that raises measured enterolactone in a person is a question no trial of this pair has answered.
Inulin is fermented in the proximal colon, lowering pH and feeding the same genera that carry out lignan conversion. That is the mechanistic case for pairing a prebiotic with a lignan. It is an argument about the environment rather than a demonstrated increase in enterolactone production.
Fructooligosaccharides selectively feed bifidobacteria and lactobacilli, the genera involved in the enterolignan conversion sequence. Pairing them with a lignan is a substrate-plus-environment strategy. No trial has measured whether the combination changes enterolactone output.
Galactooligosaccharides are fermented by bifidobacteria in the proximal colon, shifting the environment in which lignan conversion takes place. The rationale for combining them with a lignan is environmental. It has not been tested as a pair.
Resistant starch ferments further along the colon than inulin does, extending the region of active bacterial metabolism. Lignan conversion happens across that stretch. The pairing is mechanistically coherent and has no combination data behind it.
Psyllium increases stool bulk and shortens colonic transit, which cuts both ways for lignan conversion: less residence time for the bacterial sequence to run, but a different fermentation environment. The net direction is not established. This is worth flagging in a combined formula rather than assumed to help.
Flaxseed carries lignans concentrated in the hull, mainly as secoisolariciresinol diglucoside with matairesinol present as a minor member. Pressed flaxseed oil retains almost none of that lignan fraction unless hull material is added back. Anyone pairing the two for lignan content should read the label for whether lignans were reintroduced.
Pectin is fermented by colonic bacteria and contributes to the acidic, actively metabolising environment where lignan conversion runs. It is another environmental partner rather than a direct interactant. No combination study exists.
Oat beta glucan is both viscous and fermentable, so it slows small-intestinal transit and feeds colonic bacteria. Both properties touch the conditions under which a lignan is converted. The direction of the net effect on enterolactone production has not been measured.
Butyrate is the principal energy substrate of colonocytes and is produced by the fermentative community that also carries out lignan conversion. Supplying it directly does not perform the conversion, so read the pairing as supporting the same colonic environment rather than driving the lignan step. This is mechanism, not a measured combination effect.
Enterolactone is glucuronidated in the liver and excreted in bile, then partly deconjugated by bacterial beta-glucuronidase and reabsorbed. Calcium D-glucarate is proposed to inhibit that bacterial deconjugation step, which would shift the balance toward excretion rather than recycling. The mechanism is described in the literature on glucuronidation; the effect on enterolignan levels specifically has not been measured.
Enterolignans derived from matairesinol bind oestrogen receptors with far lower affinity than estradiol, and DIM is studied against hydroxylation pathways of oestrogen metabolism. A crossover trial in healthy postmenopausal women measured urinary oestrogen and phytoestrogen metabolites after a dietary intervention, showing this whole area is assessed by markers. These are markers of metabolism, not clinical outcomes, and the pairing has not been tested.
Matairesinol carries guaiacyl phenolic groups that donate hydrogen atoms and become phenoxyl radicals when they do. Ascorbate can reduce those radicals back to the parent phenol in solution. This is standard model-system chemistry and does not describe an outcome in a person.
Sulforaphane acts through Nrf2-driven induction of conjugating enzymes, a transcriptional route unrelated to lignan conversion. Both ingredients appear in the same class of formula aimed at supporting normal detoxification and hormone metabolism. There is no combination evidence and the shared placement is a category convention.
Partially hydrolysed guar gum ferments slowly and with less gas than inulin, which is why it is chosen where tolerability matters. It supports the same colonic bacteria involved in lignan conversion. The rationale is environmental and untested for this specific pairing.
Nothing specific on file for Matairesinol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Matairesinol actually does.
Matairesinol is a dibenzylbutyrolactone plant lignan formed from two coniferyl alcohol units through pinoresinol and lariciresinol, a route shared with the biosynthesis of lignin.
Matairesinol is not the circulating active species: colonic bacteria convert it to the enterolignan enterolactone through demethylation and dehydroxylation, and enterolactone is what is absorbed and measured in plasma and urine.
Because the conversion depends on the resident microbiota, enterolactone production varies widely between individuals given the same lignan intake, and antibiotic exposure lowers it.
Enterolactone is conjugated in the liver by glucuronidation and sulfation, excreted in bile, and partly deconjugated by bacterial beta-glucuronidase and reabsorbed, which is a classic enterohepatic circulation.
Where Matairesinol comes from.
The lignans sit in the outer hull of flax seed, and a related one sits in spruce knots. The plant material is ground and soaked in alcohol to pull the lignans out, treated to free them from the plant fibre they are bound to, then cleaned up on a resin column, checked for strength, and dried into a powder.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Lignans are concentrated in the seed coat of flax, available as a by-product of flax processing, and separately in the knots of Norway spruce, where the related hydroxymatairesinol predominates.
The milled feedstock is extracted with alcohol or an alcohol-water mixture, which dissolves the lignan glycosides away from the fibre and oil.
Alkaline or enzymatic hydrolysis releases the aglycone lignans from the ester-linked polymeric complex they occur in within the hull.
Adsorption resin or chromatographic steps separate the lignan fraction from residual sugars, phenolic acids and cyanogenic glycosides carried over from the seed.
Batches are quantified by chromatography against a declared lignan content, most often total lignans or secoisolariciresinol diglucoside rather than matairesinol alone.
The purified fraction is concentrated and spray dried, usually onto a carrier, giving a powder that can be encapsulated.
Labels commonly declare total lignans or SDG content rather than matairesinol specifically, and rarely state whether the material is seed-derived matairesinol or spruce-derived hydroxymatairesinol.
Getting Matairesinol from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across pooled trials of plant lignans and other phytoestrogens in women past reproductive age, no consistent reduction in hot flush frequency was detected compared with placebo.Meta-analysis. Lethaby et al., 2013 (The Cochrane database of systematic reviews). PMID 24323914 ↗
- A flaxseed lignan intervention in older women raised production of the enterolignans that lignans such as matairesinol are converted into, with wide variation between individuals.Randomised trial. McCann et al., 2021 (Nutrients). PMID 33809130 ↗
- Adding dietary seaweed to the diet altered measured urinary oestrogen and phytoestrogen metabolite patterns, with lignan metabolites among those tracked; these are metabolic markers rather than clinical outcomes.Randomised trial. Teas J et al., 2009 (The Journal of Nutrition). PMID 19321575 ↗
- Computational docking and simulation were used to describe how matairesinol binds a set of candidate protein targets, with supporting cell-based work; mechanistic and preclinical only.In vitro study. Chaudhary A et al., 2026 (Journal of Biomolecular Structure and Dynamics). PMID 40135676 ↗
These are the studies our verdict leans on, chosen from the 269 we read for Matairesinol. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.